Söring starts neurosurgical research project

On August 1st, Söring will start the three-year research project "UltraLas", which aims to improve tumour detection and thus enable an even more precise and low-risk resection of neurosurgical lesions. Over the next three years an interdisciplinary team from Germany will work on developing and evaluating various measurement methods for the intraoperative in vivo recognition of tumour extent, vascular architecture and tumor elasticity for neurosurgery. The main objective will be the reliable detection of tumor tissue, which is still difficult or involves great technological effort. The more reliably the edges of brain tumors can be determined, the more accurately the lesions can be resected – e.g. with Söring Micro instruments. For the patients’ health it is extremely important to remove the cancerous tissue as completely as possible and at the same time to preserve adjacent healthy brain tissue and larger blood vessels. The interdisciplinary team hopes that the new methods will increase the extent of resection, reduce the patient's risk and prolong their life. In addition to Söring, two research institutes, a laser company and the Department of Neurosurgery of the University Hospital Schleswig-Holstein (UKSH) are involved in the project, which is funded by the Federal Ministry of Education and Research (BMBF). Source: Soering GmbH Press Release from July 31st, 2018, https://www.soering.de/en/news-events/article/news/soering-starts-neurosurgical-research-project/

More News

The large and lively “HALRIC family” gathered in Lund in February to recap the three amazing years of the project and look ahead to the future. (Photo: HALRIC)
The large and lively “HALRIC family” gathered in Lund in February to recap the three amazing years of the project and look ahead to the future. (Photo: HALRIC)

HALRIC Strengthens Life Science Connections in Northern Europe

After three years, Life Science Nord has issued a positive assessment of the Interreg project HALRIC – Hanseatic Life Science Research Infrastructure Consortium. The project’s ...

Read more …
Dr. Fernando Delgado (CTO), Dr. Michael Hartung (CPO), Alexander Zahn (CEO), and Prof. Dr. Jan Baumbach (CSO) (from left) founded the company in Hamburg in 2025. (Photo: Galagos)
Dr. Fernando Delgado (CTO), Dr. Michael Hartung (CPO), Alexander Zahn (CEO), and Prof. Dr. Jan Baumbach (CSO) (from left) founded the company in Hamburg in 2025. (Photo: Galagos)

#NEWatLSN: Galagos

We are delighted to welcome Galagos as a new member of Life Science Nord e.V.! The founding team answered questions about the company’s initial goals, ...

Read more …
The meetings brought together senior representatives from the European Commission and multiple Member States. (Picture: HALRIC)
The meetings brought together senior representatives from the European Commission and multiple Member States. (Picture: HALRIC)

HALRIC in Brussels

Through direct dialogue with the European Commission and Member States, HALRIC’s Brussels discussions showed how cross-border life science collaboration can unlock efficiency, strengthen European competitiveness, ...

Read more …